HDAC6 and liver dysplastic nodule: In summary, we investigated the connectivity map (CMap) with tubulointerstitial transcriptomic profiles of renal biopsy-proven DN patients and identified CAY10603, a specific inhibitor of HDAC6, as a potential drug for treating kidney tubular damage.